表紙
市場調查報告書

老年癡呆症診斷檢查裝置:醫療設備的開發平台評估

Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019

出版商 GlobalData 商品編碼 351350
出版日期 內容資訊 英文 431 Pages
訂單完成後即時交付
價格
Back to Top
老年癡呆症診斷檢查裝置:醫療設備的開發平台評估 Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019
出版日期: 2019年12月15日內容資訊: 英文 431 Pages
簡介

本報告提供老年癡呆症診斷檢查裝置的開發中產品相關調查,提供您各開發階段趨勢和產品的主要開發企業,現在進行中的臨床實驗,產業的最近事件等資訊。

第1章 目錄

第2章 簡介

  • 老年癡呆症診斷檢查裝置概要

第3章 開發中的產品

  • 開發中產品:各開發階段
  • 開發中產品:地區 (國家) 別
  • 開發中產品:法規途徑別
  • 開發中產品:核准時期別 (估計)
  • 進行中臨床實驗

第4章 老年癡呆症診斷檢查裝置 - 正在開發的開發中產品:各企業

  • 老年癡呆症診斷檢查裝置的開發企業 - 開發中產品:各開發階段
  • 開發中產品:各開發階段

第5章 老年癡呆症診斷檢查裝置的開發企業與產品概要

  • AC Immune SA
  • Acobiom
  • Acumen Pharmaceuticals, Inc.
  • Adlyfe Inc.
  • Advanced Genomic Technology, LLC
  • ADx NeuroSciences NV
  • Akrivis Technologies, LLC
  • Alere Inc.
  • Alzhyme Pty Ltd
  • Amarantus Bioscience Holdings, Inc.
  • Applied Proteomics, Inc.
  • Araclon Biotech, S.L.
  • Banyan Biomarkers, Inc.
  • BioArctic Neuroscience AB
  • biOasis Technologies Inc.
  • Biomedical Development Corporation
  • BioSystems International
  • C2N Diagnostics LLC
  • Chronix Biomedical, Inc.
  • Cognoptix, Inc.
  • Columbia University
  • CompanDX Ltd.
  • Consejo Superior de Investigaciones Cientificas
  • Cymedx
  • DiaGenic ASA
  • DiamiR LLC
  • DiaPat GmbH
  • Diaxonhit S.A.
  • Dr. Grossegger & Drbal GmbH
  • DS Pharma Biomedical Co., Ltd.
  • Durin Technologies, Inc.
  • Emory University
  • Fianostics GmbH
  • Gene Solutions LLC
  • GeneNews Limited
  • Genentech, Inc.
  • Georg-August-Universitat Gottingen
  • Ghent University
  • HealthTell, Inc.
  • ICDD-sas
  • Innovative California Biosciences International, Inc.
  • Innovative Health Diagnostics
  • Institut National de la Sante et de la Recherche Medicale
  • Instituto de Estructura de la Materia
  • Integrated Diagnostics Inc.
  • Janssen Pharmaceutica N.V.
  • KineMed, Inc.
  • Laboratory Corporation of America Holdings
  • McGill University Health Center
  • Memory Dx, LLC
  • Meso Scale Diagnostics LLC
  • Myriad Genetics, Inc.
  • NanoSomiX, Inc.
  • Nanosphere, Inc.
  • Neuron Biopharma SA
  • NeuroQuest, Ltd.
  • Neurotrope Bioscience, Inc.
  • NeuroVision Imaging LLC.
  • Newcastle University
  • NextGen Sciences Dx Inc
  • Novel Bio-spectrum Technologies, Inc.
  • Oligomerix, inc.
  • OPKO Health, Inc.
  • Orasi Medical, Inc.
  • Oregon Health & Science University
  • Oryzon Genomics S.A.
  • Oxford Biodynamics Limited
  • PDx BioTech
  • PeriRx LLC
  • Pre Diagnostics AS
  • Predemtec GmbH
  • ProMIS Neurosciences Inc.
  • Proplex Technologies, Llc
  • Protagen AG
  • Proteome Sciences Plc
  • Proteomics International Pty Ltd
  • Quanterix Corporation
  • Redox Diagnostics LLC
  • Saladax Biomedical, Inc.
  • Satoris, Inc.
  • Scout Diagnostics, LLC
  • Singulex, Inc.
  • SomaLogic, Inc.
  • Takeda Pharmaceuticals International AG
  • The Johns Hopkins University
  • The University of Melbourne
  • Trinity College Dublin
  • True Diagnostics, Inc.
  • University of California, Irvine
  • University of Chicago
  • University of Georgia
  • University of Luxembourg
  • University of Nottingham
  • University of South Florida
  • University of Texas Health Science Center at Houston
  • University of Texas Southwestern Medical Center at Dallas
  • US Biomarkers, Inc.
  • Vermillion, Inc.
  • Vitruvian Biomedical, Inc.
  • Washington University in St. Louis
  • XRGenomics LTD
  • Zoiray Technologies Inc.

第6章 老年癡呆症診斷檢查裝置 - 最近的事件

第7章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0835EPD

GlobalData's Medical Devices sector report, "Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019" provides an overview of Alzheimer Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Alzheimer Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Alzheimer Diagnostic Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Alzheimer Diagnostic Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Alzheimer Diagnostic Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1 List of Tables 12
  • 1.2 List of Figures 20

2 Introduction 21

  • 2.1 Alzheimer Diagnostic Tests Overview 21

3 Products under Development 22

  • 3.1 Alzheimer Diagnostic Tests - Pipeline Products by Stage of Development 22
  • 3.2 Alzheimer Diagnostic Tests - Pipeline Products by Territory 23
  • 3.3 Alzheimer Diagnostic Tests - Pipeline Products by Regulatory Path 24
  • 3.4 Alzheimer Diagnostic Tests - Pipeline Products by Estimated Approval Date 25
  • 3.5 Alzheimer Diagnostic Tests - Ongoing Clinical Trials 26

4 Alzheimer Diagnostic Tests - Pipeline Products under Development by Companies 27

  • 4.1 Alzheimer Diagnostic Tests Companies - Pipeline Products by Stage of Development 27
  • 4.2 Alzheimer Diagnostic Tests - Pipeline Products by Stage of Development 32

5 Alzheimer Diagnostic Tests Companies and Product Overview 37

6 Alzheimer Diagnostic Tests - Recent Developments 191

7 Appendix 419

List of Tables

  • Table 1: Alzheimer Diagnostic Tests - Pipeline Products by Stage of Development 22
  • Table 2: Alzheimer Diagnostic Tests - Pipeline Products by Territory 23
  • Table 3: Alzheimer Diagnostic Tests - Pipeline Products by Regulatory Path 24
  • Table 4: Alzheimer Diagnostic Tests - Pipeline Products by Estimated Approval Date 25
  • Table 5: Alzheimer Diagnostic Tests - Ongoing Clinical Trials 26
  • Table 6: Alzheimer Diagnostic Tests Companies - Pipeline Products by Stage of Development 27
  • Table 7: Alzheimer Diagnostic Tests - Pipeline Products by Stage of Development 32
  • Table 8: AC Immune SA Pipeline Products & Ongoing Clinical Trials Overview 37
  • Table 9: Abeta-Based Diagnostic Test - Alzheimer´s Disease - Product Status 37
  • Table 10: Abeta-Based Diagnostic Test - Alzheimer´s Disease - Product Description 38
  • Table 11: pTau-Based Diagnostic Test - Alzheimer´s Disease - Product Status 38
  • Table 12: pTau-Based Diagnostic Test - Alzheimer´s Disease - Product Description 38
  • Table 13: Acobiom Pipeline Products & Ongoing Clinical Trials Overview 39
  • Table 14: Companion Diagnostic Test - Alzheimer's Disease - Product Status 39
  • Table 15: Companion Diagnostic Test - Alzheimer's Disease - Product Description 39
  • Table 16: Diagnostic/Prognostic Assay - Alzheimer's Disease - Product Status 40
  • Table 17: Diagnostic/Prognostic Assay - Alzheimer's Disease - Product Description 40
  • Table 18: Acumen Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 41
  • Table 19: Ultra-high Sensitivity Companion Diagnostic Assay - Product Status 41
  • Table 20: Ultra-high Sensitivity Companion Diagnostic Assay - Product Description 41
  • Table 21: Adlyfe Inc Pipeline Products & Ongoing Clinical Trials Overview 42
  • Table 22: Diagnostic Assay - Alzheimer's Disease - Product Status 42
  • Table 23: Diagnostic Assay - Alzheimer's Disease - Product Description 42
  • Table 24: Admit Therapeutics SL Pipeline Products & Ongoing Clinical Trials Overview 43
  • Table 25: Diagnostic Test - Alzheimer's Disease - Product Status 43
  • Table 26: Diagnostic Test - Alzheimer's Disease - Product Description 43
  • Table 27: ADx NeuroSciences NV Pipeline Products & Ongoing Clinical Trials Overview 44
  • Table 28: ADDL'S Biomarker Test - Product Status 44
  • Table 29: ADDL'S Biomarker Test - Product Description 45
  • Table 30: Biomarker Assay - Amyloid Ratio High Sensitivity - Product Status 45
  • Table 31: Biomarker Assay - Amyloid Ratio High Sensitivity - Product Description 45
  • Table 32: Biomarker Assay - P-Tau Isoforms - Product Status 46
  • Table 33: Biomarker Assay - P-Tau Isoforms - Product Description 46
  • Table 34: Biomarker Assay - Tau Isoforms - Product Status 46
  • Table 35: Biomarker Assay - Tau Isoforms - Product Description 46
  • Table 36: Blood Based Amyloid Beta Biomarker Test - Product Status 47
  • Table 37: Blood Based Amyloid Beta Biomarker Test - Product Description 47
  • Table 38: GLOB. P3N AB Biomarker Test - Product Status 47
  • Table 39: GLOB. P3N AB Biomarker Test - Product Description 48
  • Table 40: O-TAU Biomarker Test - Product Status 48
  • Table 41: O-TAU Biomarker Test - Product Description 48
  • Table 42: SNAP 25 Biomarker Test - Product Status 49
  • Table 43: SNAP 25 Biomarker Test - Product Description 49
  • Table 44: Synuclein Oligo Biomarker Test - Product Status 49
  • Table 45: Synuclein Oligo Biomarker Test - Product Description 50
  • Table 46: Aelan Cell Technologies Pipeline Products & Ongoing Clinical Trials Overview 51
  • Table 47: Diagnostic Blood Test - Alzheimer's Disease - Product Status 51
  • Table 48: Diagnostic Blood Test - Alzheimer's Disease - Product Description 51
  • Table 49: Agent Biotech Pipeline Products & Ongoing Clinical Trials Overview 52
  • Table 50: Diagnostic Test - Alzheimer's Disease - Product Status 52
  • Table 51: Diagnostic Test - Alzheimer's Disease - Product Description 52
  • Table 52: Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview 53
  • Table 53: Mitochondrial Preprotein Based Test - Alzheimer's Disease - Product Status 53
  • Table 54: Mitochondrial Preprotein Based Test - Alzheimer's Disease - Product Description 53
  • Table 55: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 54
  • Table 56: Diagnostic Assay - Alzheimer's Disease - Product Status 54
  • Table 57: Diagnostic Assay - Alzheimer's Disease - Product Description 54
  • Table 58: Alzhyme Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 55
  • Table 59: Diagnostic Test - Alzheimer's Disease - Product Status 55
  • Table 60: Diagnostic Test - Alzheimer's Disease - Product Description 55

List of Figures

  • Figure 1: Alzheimer Diagnostic Tests - Pipeline Products by Stage of Development 22
  • Figure 2: Alzheimer Diagnostic Tests - Pipeline Products by Territory 23
  • Figure 3: Alzheimer Diagnostic Tests - Pipeline Products by Regulatory Path 24
  • Figure 4: Alzheimer Diagnostic Tests - Pipeline Products by Estimated Approval Date 25
  • Figure 5: Alzheimer Diagnostic Tests - Ongoing Clinical Trials 26
Back to Top